News – Page 470 – Endpoints News

#ESC22: 89bio heads toward PhIII in severe hypertriglyceridemia, a field left behind by Pfizer earlier this year

3 years ago

No Myth: CEO of ADC upstart calls it quits; Bristol Myers vet Jon Wigginton scales new heights at Bright Peak

3 years ago

A push for transparency: US to make all federally-funded research public

3 years ago

Alnylam draws on patient artist’s striking depictions of life with a rare genetic disease in new ad campaign

3 years ago

China and US consider possible solution for US-listed companies in violation of new law — report

3 years ago

Pfizer teams with historically Black university for new vaccine public health doctorate program

3 years ago

J&J and AbbVie's blockbuster BTK inhibitor scoops a pediatric indication in graft-versus-host disease

3 years ago

European Commission unveils long-awaited revision to guideline on sterile drug manufacturing

3 years ago

Manufacturing roundup: Chinese CDMO nets $80M+ Series B; $11M expansion on the books for manufacturer in NC

3 years ago

Beijing CRO expands agreement with Merck KGaA; Early-stage venture firm closes its first fund

3 years ago

Researchers inch closer in effectively (and non-toxically) marrying CRISPR and CAR-T

3 years ago

Armed with $100M grant, ElevateBio looks to create biomanufacturing center with the University of Pittsburgh

3 years ago

Moderna co-founder, ex-Bayer CEO jump aboard Belgian RNA biotech, investing in Series B round

3 years ago

French penny stock will no longer knock on FDA door for approval in a certain type of blood cancer

3 years ago

Pfizer heads to the FDA with an early lead over rivals in the $10B RSV vaccine market

3 years ago

Facing fears of neuronal damage, Novartis slams brakes on Huntington's trial

3 years ago

BioMarin nets conditional approval for valrox in Europe, marking the first hemophilia gene therapy

3 years ago

Radioligands are going on air: Aktis gains third Big Pharma backer

3 years ago

Searching for new TCR targets, immunotherapy startup emerges with Stanford tech, $40M round

3 years ago

After wrestling with the Sandoz problem for several years, Vas Narasimhan settles on a spinout

3 years ago

Pfizer's Paxlovid only helped seniors avoid hospitalization and death, new NEJM study finds

3 years ago

Inovio agrees to shell out $44M to settle Covid-19 vaccine lawsuit

3 years ago

House investigates Trump’s ‘inappropriate’ pressure on FDA during the pandemic

3 years ago

US considers use of expired monkeypox vaccines amid rising demand for doses

3 years ago

First page Previous page 467 468 469470471 472 473 Next page Last page